Faricimab at 6 and 12 mg reduces pigment epithelium detachment in treatment-resistant macular neovascularization: an OCT and AI analysis.

Saved in:
Bibliographic Details
Title: Faricimab at 6 and 12 mg reduces pigment epithelium detachment in treatment-resistant macular neovascularization: an OCT and AI analysis.
Authors: Nagel, Ines D.1,2 (AUTHOR), Tran, Melanie D.1,3 (AUTHOR), Zhang, Haochen4 (AUTHOR), Cheng, Lingyun1,2 (AUTHOR), Heinke, Anna1,2 (AUTHOR), Mehta, Nehal N.1,2 (AUTHOR), Bartsch, Dirk-Uwe1,2 (AUTHOR), Kalaw, Fritz G. P.1,2,4 (AUTHOR), Morsy, Mohamed1,2 (AUTHOR), Mueller, Arthur J.5 (AUTHOR), Freeman, William R.1,2 (AUTHOR) wrfreeman@health.ucsd.edu
Source: Scientific Reports. 9/30/2025, Vol. 15 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-025-09910-2